Medical News

RSS

International Association of Eating Disorders Professionals to kick off 27th annual symposium

The International Association of Eating Disorders Professionals (iaedp) kicks off its 27th annual Symposium March 21-24 at the Westin Lake Las Vegas Resort and Spa and will feature five nationally recognized professionals addressing new treatments and research concerning eating disorders.

10 Feb 2013

Care Investment Trust enters joint venture with affiliates of Calamar

Care Investment Trust Inc., a real estate investment company that invests in healthcare and seniors-related real estate, today announced that effective as of February 1, 2013, it entered into a joint venture with affiliates of Calamar Enterprises, Inc., owned 75% by affiliates of Care and 25% by affiliates of Calamar, for the acquisition of two senior apartment communities from affiliates of Calamar with an aggregate value of $23.3 million.

10 Feb 2013

Roundup: Conn. governor's budget proposal would shed thousands from Medicaid; Insurance rates to rise 2.7% in Mass.; Calif. group wants tighter doc narcotic control

Gov. Dannel Malloy said he would close Connecticut's $1.2 billion budget gap with a mix of spending cuts, including to hospitals and programs for the poor, and new revenues, including the extension of some business taxes that were scheduled to expire.

10 Feb 2013

MMRF joins multiple myeloma community in celebrating FDA accelerated approval of Pomalyst

The Multiple Myeloma Research Foundation (MMRF) today joined the multiple myeloma community in celebrating the U.S. Food and Drug Administration's (FDA) decision to grant accelerated approval of Pomalyst (Celgene Corporation, pomalidomide) for the treatment of patients with relapsed and refractory multiple myeloma who no longer respond to currently available treatments.

10 Feb 2013

Shire commences ABH001 Phase 3 study in Epidermolysis Bullosa

Shire plc, today announced the initiation of a Phase 3 study designed to evaluate the efficacy and safety of ABH001, its dermal substitute therapy, for the treatment of non-healing wounds in patients with Epidermolysis Bullosa (EB), a group of rare genetic skin disorders that begin to manifest at birth or early childhood and occur in approximately 19 per 1 million live births in the US.

10 Feb 2013

Northwestern Medicine to open new Outpatient Center in Glenview, Illinois

Northwestern Medicine today announced that on March 1 it will open a new Outpatient Center at 2701 Patriot Boulevard in Glenview, Illinois. At this new center, 20-30 physicians will offer patients a wide range of primary care and specialty clinical services.

10 Feb 2013

Accuray announces pricing of $100 million convertible senior notes due 2018

Accuray Incorporated today announced the pricing of its offering of $100 million aggregate principal amount of 3.50% convertible senior notes due 2018.

10 Feb 2013

Researchers develop special version of iDichotic for patients with schizophrenia

Two years ago, researcher Josef Bless was listening to music on his phone when he suddenly had an idea. "I noticed that the sounds of the different instruments were distributed differently between the ears, and it struck me that this was very similar to the tests we routinely use in our laboratory to measure brain function. In dichotic listening, each ear is presented with a different syllable at the same time and the listener has to say which syllable seems clearest. The test indicates which side of the brain is most active during language processing," Bless explains.

10 Feb 2013

TGFβ inhibition enhances chemotherapy action against triple negative breast cancer

Due to chemotherapy resistance and a high rate of relapse, triple negative cancers are among the most difficult breast cancers to treat. In this issue of the Journal of Clinical Investigation, researchers led by Carlos Arteaga at Vanderbilt University identified a protein, TGF-β, that is highly expressed in triple negative breast cancer cells after chemotherapy.

10 Feb 2013

Social networking sites could effectively help prevent HIV infection among at-risk groups

Facebook and other social networking technologies could serve as effective tools for preventing HIV infection among at-risk groups, new UCLA research suggests.

9 Feb 2013

Weekend reading: Mental health discrimination; A doctor faces hard questions; Long-term outlook for health care jobs

"When I had cancer, I got cards and flowers," Karen Kangas' sign reads. "When I was diagnosed with bipolar disorder, I got no cards and a pink slip." A picture of Kangas holding the sign hangs in the state Capitol complex, part of an exhibit called "Discrimination: A Roadblock to Recovery."

9 Feb 2013

Neurocrine Biosciences fourth quarter net income increases to $9.5 million

Neurocrine Biosciences, Inc. today announced its financial results for the quarter and year ended December 31, 2012.

9 Feb 2013

LPA genetic variant increases risk of heart valve calcification

Researchers have found a genetic variant that doubles the likelihood that people will have calcium deposits on their aortic valve. Such calcification, if it becomes severe, can cause narrowing or a blockage of the aortic valve, a condition called aortic stenosis.

9 Feb 2013

Study finds reason why patients with chronic pain often suffer from impaired short -term memory

A group of Portuguese researchers from IBMC and FMUP at the University of Porto has found the reason why patients with chronic pain often suffer from impaired short -term memory.

9 Feb 2013

Marijuana may double stroke risk in young adults

Marijuana, the most widely used illicit drug, may double stroke risk in young adults, according to research presented at the American Stroke Association's International Stroke Conference 2013.

9 Feb 2013

First Edition: February 8, 2013

Today's early morning highlights from the major news organizations, including reports about Marilyn Tavenner's nomination to run Medicare and the Catholic bishops' rejection of the Obama administration's contraception plan announced last week.

9 Feb 2013

Positive data from Oncolytics' REOLYSIN Phase 2 combination trial on SCCLC

Oncolytics Biotech Inc. today announced results examining percent overall tumour shrinkage data from its U.S. Phase 2 clinical trial in patients with squamous cell carcinoma of the lung (SCCLC) using intravenous administration of REOLYSIN in combination with carboplatin and paclitaxel (REO 021).

9 Feb 2013

Medical News

International Association of Eating Disorders Professionals to kick off 27th annual symposium

Care Investment Trust enters joint venture with affiliates of Calamar

Roundup: Conn. governor's budget proposal would shed thousands from Medicaid; Insurance rates to rise 2.7% in Mass.; Calif. group wants tighter doc narcotic control

MMRF joins multiple myeloma community in celebrating FDA accelerated approval of Pomalyst

Shire commences ABH001 Phase 3 study in Epidermolysis Bullosa

Northwestern Medicine to open new Outpatient Center in Glenview, Illinois

Accuray announces pricing of $100 million convertible senior notes due 2018

Researchers develop special version of iDichotic for patients with schizophrenia

TGFβ inhibition enhances chemotherapy action against triple negative breast cancer

Social networking sites could effectively help prevent HIV infection among at-risk groups

Weekend reading: Mental health discrimination; A doctor faces hard questions; Long-term outlook for health care jobs

Neurocrine Biosciences fourth quarter net income increases to $9.5 million

LPA genetic variant increases risk of heart valve calcification

Study finds reason why patients with chronic pain often suffer from impaired short -term memory

Marijuana may double stroke risk in young adults

First Edition: February 8, 2013

Positive data from Oncolytics' REOLYSIN Phase 2 combination trial on SCCLC

Gilead Sciences acquires YM BioSciences

Political cartoon: 'Coming To Your Neighborhood Soon?'

Planmed Verity Extremity Scanner receives FDA clearance

Voltammetry and machine learning for real-time neurotransmitter detection

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

Latest News